There are a number of reasons why you should make a weight loss vision board. Here are five easy ways to get started and find ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows of medical journals. The newest generation ...

A groundbreaking study has unveiled potential concerns regarding semaglutide, the active ingredient in popular weight loss medications like Ozempic and Wegovy. The research suggests a possible ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why this may ...

Vision issues are rare but usually permanent Researchers point to the popularity of drugs as cause for concern Previous medications linked to vision issues have had label changes Vision issues are ...

Weight-loss drugs may cause serious eye diseases leading to vision loss in some people, two new studies suggest. One study, published in JAMA, assessed data from nearly 1.5 million people and found ...

Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

Two Massachusetts women have filed separate federal lawsuits against pharmaceutical giant Novo Nordisk, of Plainsboro, alleging the company’s popular weight-loss medication Wegovy caused them to ...

While reviewing patient cases with residents one morning, Joseph F. Rizzo III, MD, mentioned he recently cared for a patient who had taken semaglutide and developed severe optic neuropathy. One ...